Atherosclerosis is the underlying etiology of cardiovascular disease, the leading cause of death worldwide. Atherosclerosis is a heterogeneous disease in which only a small fraction of lesions lead to heart attack, stroke, or sudden cardiac death. A distinct type of plaque containing large necrotic cores with thin fibrous caps often precipitates these acute events. Here, we show that Ca2+/calmodulin-dependent protein kinase γ (CaMKIIγ) in macrophages plays a major role in the development of necrotic, thin-capped plaques. Macrophages in necrotic and symptomatic atherosclerotic plaques in humans as well as advanced atherosclerotic lesions in mice demonstrated activation of CaMKII. Western diet–fed LDL receptor–deficient (Ldlr–/–) mice with myeloid-specific deletion of CaMKII had smaller necrotic cores with concomitantly thicker collagen caps. These lesions demonstrated evidence of enhanced efferocytosis, which was associated with increased expression of the macrophage efferocytosis receptor MerTK. Mechanistic studies revealed that CaMKIIγ-deficient macrophages and atherosclerotic lesions lacking myeloid CaMKIIγ had increased expression of the transcription factor ATF6. We determined that ATF6 induces liver X receptor-α (LXRα), an Mertk-inducing transcription factor, and that increased MerTK expression and efferocytosis in CaMKIIγ-deficient macrophages is dependent on LXRα. These findings identify a macrophage CaMKIIγ/ATF6/LXRα/MerTK pathway as a key factor in the development of necrotic atherosclerotic plaques.
Amanda C. Doran, Lale Ozcan, Bishuang Cai, Ze Zheng, Gabrielle Fredman, Christina C. Rymond, Bernhard Dorweiler, Judith C. Sluimer, Joanne Hsieh, George Kuriakose, Alan R. Tall, Ira Tabas
Title and authors | Publication | Year |
---|---|---|
Efferocytosis: The Janus‐Faced Gatekeeper of Aging and Tumor Fate
Liu Z, Li Y, Ren Y, Chen J, Weng S, Zhou Z, Luo P, Chen Q, Xu H, Ba Y, Zuo A, Liu S, Zhang Y, Pan T, Han X |
Aging Cell | 2025 |
Emerging Gene Therapy Based on Nanocarriers: A Promising Therapeutic Alternative for Cardiovascular Diseases and a Novel Strategy in Valvular Heart Disease
Yang H, Li J, Song C, Li H, Luo Q, Chen M |
International Journal of Molecular Sciences | 2025 |
Macrophage profiling in atherosclerosis: understanding the unstable plaque.
Gianopoulos I, Daskalopoulou SS |
Basic Research in Cardiology | 2024 |
Targeted delivery of MerTK protein via cell membrane engineered nanoparticle enhances efferocytosis and attenuates atherosclerosis in diabetic ApoE(-/-) Mice.
Qiu S, Liu J, Chen J, Li Y, Bu T, Li Z, Zhang L, Sun W, Zhou T, Hu W, Yang G, Yuan L, Duan Y, Xing C |
Journal of nanobiotechnology | 2024 |
Cholesterol trafficking to the ER leads to the activation of CaMKII/JNK/NLRP3 and promotes atherosclerosis
Yalcinkaya M, Liu W, Xiao T, Abramowicz S, Wang R, Wang N, Westerterp M, Tall AR |
Journal of lipid research | 2024 |
Mechanism of efferocytosis in atherosclerosis.
Shu LX, Cao LL, Guo X, Wang ZB, Wang SZ |
Journal of Molecular Medicine | 2024 |
Macrophage polarisation and inflammatory mechanisms in atherosclerosis: Implications for prevention and treatment
Yang B, Hang S, Xu S, Gao Y, Yu W, Zang G, Zhang L, Wang Z |
Heliyon | 2024 |
Lipid droplet-associated hydrolase mobilizes stores of liver X receptor sterol ligands and protects against atherosclerosis
Goo YH, Plakkal Ayyappan J, Cheeran FD, Bangru S, Saha PK, Baar P, Schulz S, Lydic TA, Spengler B, Wagner AH, Kalsotra A, Yechoor VK, Paul A |
Nature Communications | 2024 |
Clearing the Path: Exploring Apoptotic Cell Clearance in Inflammatory and Autoimmune Disorders for Therapeutic Advancements.
Ghorbanzadeh S, Khojini JY, Abouali R, Alimardan S, Zahedi M, Tahershamsi Z, Tajbakhsh A, Gheibihayat SM |
Molecular biotechnology | 2024 |
Efferocytosis: the resolution of inflammation in cardiovascular and cerebrovascular disease
Zhang B, Zou Y, Yuan Z, Jiang K, Zhang Z, Chen S, Zhou X, Wu Q, Zhang X |
Frontiers in Immunology | 2024 |
Sigma-1 receptor-regulated efferocytosis by infiltrating circulating macrophages/microglial cells protects against neuronal impairments and promotes functional recovery in cerebral ischemic stroke
Zhang G, Li Q, Tao W, Qin P, Chen J, Yang H, Chen J, Liu H, Dai Q, Zhen X |
Theranostics | 2023 |
Small Molecule Activation of NAPE-PLD Enhances Efferocytosis by Macrophages
Zarrow JE, Alli-Oluwafuyi AM, Youwakim CM, Kim K, Jenkins AN, Suero IC, Jones MR, Mashhadi Z, Mackie KP, Waterson AG, Doran AC, Sulikowski GA, Davies SS |
2023 | |
Damage-mediated macrophage polarization in sterile inflammation
Koncz G, Jenei V, Tóth M, Váradi E, Kardos B, Bácsi A, Mázló A |
Frontiers in immunology | 2023 |
Small Molecule Activation of NAPE-PLD Enhances Efferocytosis by Macrophages
Zarrow JE, Alli-Oluwafuyi AM, Youwakim CM, Kim K, Jenkins AN, Suero IC, Jones MR, Mashhadi Z, Mackie K, Waterson AG, Doran AC, Sulikowski GA, Davies SS |
ACS chemical biology | 2023 |
The Role of Macrophages in Atherosclerosis: Participants and Therapists.
Liu X, Pang S, Jiang Y, Wang L, Liu Y |
Cardiovascular Drugs and Therapy | 2023 |
The role of efferocytosis-fueled macrophage metabolism in the resolution of inflammation
Schilperoort M, Ngai D, Sukka SR, Avrampou K, Shi H, Tabas I |
Immunological Reviews | 2023 |
Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?
S Engelen, A Robinson, Y Zurke, C Monaco |
Nature Reviews Cardiology | 2022 |
Inflammation Resolution: Implications for Atherosclerosis
A Doran |
Circulation research | 2022 |
Drugging the efferocytosis process: concepts and opportunities
P Mehrotra, K Ravichandran |
Nature Reviews Drug Discovery | 2022 |
Efferocytosis and Its Role in Inflammatory Disorders
Y Ge, M Huang, Y Yao |
Frontiers in Cell and Developmental Biology | 2022 |
Synthesis of siRNA nanoparticles to silence plaque-destabilizing gene in atherosclerotic lesional macrophages
X Huang, C Liu, N Kong, Y Xiao, A Yurdagul, I Tabas, W Tao |
Nature Protocols | 2022 |
Protein kinases in cardiovascular diseases
J Chen, Y Li, C Du, T Wei, T Shan, L Wang |
Chinese Medical Journal | 2022 |
Selective measurement of NAPE-PLD activity via a PLA1/2-resistant fluorogenic N-acyl-phosphatidylethanolamine analog
J Zarrow, J Tian, B Dutter, K Kim, A Doran, G Sulikowski, S Davies |
Journal of lipid research | 2022 |
Foam Cells in Atherosclerosis: Novel Insights Into Its Origins, Consequences, and Molecular Mechanisms
Y Gui, H Zheng, R Cao |
Frontiers in Cardiovascular Medicine | 2022 |
Current Development of Nano-Drug Delivery to Target Macrophages
Cai D, Gao W, Li Z, Zhang Y, Xiao L, Xiao Y |
Biomedicines | 2022 |
ILRUN Promotes Atherosclerosis through Lipid-dependent and Lipid-independent Factors
Bi X, Stankov S, Lee PC, Wang Z, Wu X, Li L, Ko YA, Cheng L, Zhang H, Hand NJ, Rader DJ |
Arteriosclerosis, thrombosis, and vascular biology | 2022 |
Targeted Diagnosis, Therapeutic Monitoring, and Assessment of Atherosclerosis Based on Mesoporous Silica Nanoparticles Coated with cRGD-Platelets
Zhang W, Lv Z, Zhang Y, Gopinath SC, Yuan Y, Huang D, Miao L |
Oxidative medicine and cellular longevity | 2022 |
Resolvin D1 Enhances Necroptotic Cell Clearance Through Promoting Macrophage Fatty Acid Oxidation and Oxidative Phosphorylation
Z Hosseini, M Marinello, C Decker, BE Sansbury, S Sadhu, BD Gerlach, RB Ramos, AP Adam, M Spite, G Fredman |
Arteriosclerosis, thrombosis, and vascular biology | 2021 |
CaMKIIδ Splice Variants in the Healthy and Diseased Heart
J Duran, L Nickel, M Estrada, J Backs, MM van den Hoogenhof |
Frontiers in Cell and Developmental Biology | 2021 |
The new insight into extracellular NAD + degradation‐the contribution of CD38 and CD73 in calcific aortic valve disease
P Jablonska, B KutrybZajac, P Mierzejewska, A Jasztal, B Bocian, R Lango, J Rogowski, S Chlopicki, RT Smolenski, EM Slominska |
Journal of Cellular and Molecular Medicine | 2021 |
Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis
W Chen, M Schilperoort, Y Cao, J Shi, I Tabas, W Tao |
Nature Reviews Cardiology | 2021 |
Targeting inflammation in atherosclerosis — from experimental insights to the clinic
O Soehnlein, P Libby |
Nature Reviews Drug Discovery | 2021 |
The role of calmodulin and calmodulin-dependent protein kinases in the pathogenesis of atherosclerosis
M Chen |
Tzu Chi Medical Journal | 2021 |
Allosteric MAPKAPK2 inhibitors improve plaque stability in advanced atherosclerosis
L Ozcan, C Kasikara, A Yurdagul, G Kuriakose, B Hubbard, MH Serrano-Wu, I Tabas, C Schulz |
PloS one | 2021 |
Dimethyl Trisulfide Diminishes Traumatic Neuropathic Pain Acting on TRPA1 Receptors in Mice
Á Dombi, C Sánta, IZ Bátai, V Kormos, A Kecskés, V Tékus, K Pohóczky, K Bölcskei, E Pintér, G Pozsgai |
International journal of molecular sciences | 2021 |
Adipsin deficiency does not impact atherosclerosis development in Ldlr−/− mice
L Liu, M Chan, L Yu, W Wang, L Qiang |
American journal of physiology. Endocrinology and metabolism | 2021 |
Metabolic Consequences of Efferocytosis and its Impact on Atherosclerosis.
Yurdagul A Jr |
Immunometabolism | 2021 |
Monocytes and Macrophages as Protagonists in Vascular Complications of Diabetes
JE Kanter, CC Hsu, KE Bornfeldt |
Frontiers in Cardiovascular Medicine | 2020 |
Macrophages Orchestrate Hematopoietic Programs and Regulate HSC Function During Inflammatory Stress
AN Seyfried, JM Maloney, KC MacNamara |
Frontiers in immunology | 2020 |
The oral Ca/calmodulin‐dependent kinase II inhibitor RA608 improves contractile function and prevents arrhythmias in heart failure
J Mustroph, M Drzymalski, M Baier, S Pabel, A Biedermann, B Memmel, M Durczok, S Neef, CM Sag, B Floerchinger, L Rupprecht, C Schmid, Y Zausig, G Bégis, V Briand, ML Ozoux, D Tamarelle, V Ballet, P Janiak, P Beauverger, LS Maier, S Wagner |
ESC Heart Failure | 2020 |
Role of Macrophages and RhoA Pathway in Atherosclerosis
M Kloc, A Uosef, JZ Kubiak, RM Ghobrial |
International journal of molecular sciences | 2020 |
Shen-Hong-Tong-Luo Formula Attenuates Macrophage Inflammation and Lipid Accumulation through the Activation of the PPAR-γ/LXR-α/ABCA1 Pathway
Z Zhang, L Zhai, J Lu, S Sun, D Wang, D Zhao, L Sun, W Zhao, X Li, Y Chen, A Ciobica |
Oxidative Medicine & Cellular Longevity | 2020 |
siRNA nanoparticles targeting CaMKIIγ in lesional macrophages improve atherosclerotic plaque stability in mice
W Tao, A Yurdagul, N Kong, W Li, X Wang, AC Doran, C Feng, J Wang, MA Islam, OC Farokhzad, I Tabas, J Shi |
Science Translational Medicine | 2020 |
Genetic Etiology Shared by Multiple Sclerosis and Ischemic Stroke
Z Tian, Y Song, Y Yao, J Guo, Z Gong, Z Wang |
Frontiers in Genetics | 2020 |
Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel
X Dai, J Meng, S Deng, L Zhang, C Wan, L Lu, J Huang, Y Hu, Z Zhang, Y Li, JF Lovell, G Wu, K Yang, H Jin |
Theranostics | 2020 |
TAM receptors and their ligand-mediated activation: Role in atherosclerosis
Cai B, Kasikara C |
International review of cell and molecular biology | 2020 |
Efferocytosis in health and disease
AC Doran, A Yurdagul, I Tabas |
Nature Reviews Immunology | 2019 |
Inflammation in nonischemic heart disease: initiation by cardiomyocyte CaMKII and NLRP3 inflammasome signaling
T Suetomi, S Miyamoto, JH Brown |
American journal of physiology. Heart and circulatory physiology | 2019 |
Human Monocyte Heterogeneity as Revealed by High-Dimensional Mass Cytometry
AA Hamers, HQ Dinh, GD Thomas, P Marcovecchio, A Blatchley, CS Nakao, C Kim, C McSkimming, AM Taylor, AT Nguyen, CA McNamara, CC Hedrick |
Arteriosclerosis, thrombosis, and vascular biology | 2019 |
Double bond configuration of palmitoleate is critical for atheroprotection
I Cimen, Z Yildirim, AE Dogan, AD Yildirim, O Tufanli, UI Onat, UT Nguyen, SM Watkins, C Weber, E Erbay |
Molecular Metabolism | 2019 |
Effects of icariin on long noncoding RNA and mRNA expression profile in the aortas of apoE-deficient mice
Y Zhang, R Xu, X Li, Q Tan, P Huang, Y Zhang, M Qin, L Ren |
Bioscience Reports | 2019 |
ER-Mitochondria Communication in Cells of the Innate Immune System
D Namgaladze, V Khodzhaeva, B Brüne |
Cells | 2019 |
Ca2+ Flux: Searching for a Role in Efferocytosis of Apoptotic Cells in Atherosclerosis
A Tajbakhsh, PT Kovanen, M Rezaee, M Banach, A Sahebkar |
Journal of Clinical Medicine | 2019 |
TAM receptors in cardiovascular disease
L McShane, I Tabas, G Lemke, M Kurowska-Stolarska, P Maffia |
Cardiovascular Research | 2019 |
LncRNA MIAT sponges miR-149-5p to inhibit efferocytosis in advanced atherosclerosis through CD47 upregulation
Z Ye, S Yang, Y Xia, R Hu, S Chen, B Li, S Chen, X Luo, L Mao, Y Li, H Jin, C Qin, B Hu |
Cell Death and Disease | 2019 |
The Role of Inflammation Resolution Mediator Imbalance in Atherosclerosis
Canan Kasikara, Amanda Doran, Bishuang Cai, Ira Tabas |
Journal of Clinical Investigation | 2018 |
A New Activator of Hepatocyte CaMKII in Fasting and Type 2 Diabetes
L Ozcan, I Tabas |
Diabetes | 2018 |
Multifaceted functions of macrophages in atherosclerosis:
CH Wu, A Daugherty, H Lu |
Current Opinion in Lipidology | 2018 |
MerTK signaling in macrophages promotes the synthesis of inflammation resolution mediators by suppressing CaMKII activity
B Cai, C Kasikara, AC Doran, R Ramakrishnan, RB Birge, I Tabas |
Science signaling | 2018 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |